At Aditum Bio our mission is to give patients access to medicines that  that promise to have a life-changing impact on their lives. Co-founded by industry veterans Joe Jimenez, former CEO of Novartis and Mark Fishman, former President of the Novartis Institutes for Biomedical Research, the firm explores scientific directions with powerful medical implications, and then seeks drug candidates that address those opportunities. Aditum is distinctive in that the team not only identifies and licenses the drug candidate but also defines, prepares for, and runs the first definitive clinical trials.

Position Summary: 

The Senior Associate will work with Aditum Bio partners to identify new investment opportunities and support the due diligence process on those opportunities, including modeling and simulation. This person will play an important role throughout the investment lifecycle, supporting activities from defining initial areas of interest, to aiding in diligence and deal negotiations and transactions, to new company formation.

Specific Responsibilities:

• Propose ideas for potential investments. The Senior Associate will research various pathways and indications, form investment theses and vet those theses with Aditum Partners, Advisors and externally curated experts.
• Perform research to help identify new investment opportunities. To evaluate drug assets of interest to Aditum Bio, the associate will develop and engage with key contacts and prospects in order to access drug assets that may be of interest to the Aditum Bio investment team
• Scientific review panels: Work closely with Aditum Bio partners and scientific advisors to discuss interim findings. Use discussions and feedback to iterate on research and recommendations.
• Deal diligence and transactions: Conduct due diligence on therapies of interest, including scientific, clinical, and financial. Work with functional Aditum Bio experts to develop clinical strategies, development plans, and budgets. Present findings at Aditum Bio Investment Committee. Work with external partners on deal discussions and transactions.
• New Company Incubation and Operations: Help lead new company incubation and operations for assets in licensed.  Translate the clinical and scientific findings from investment generation into the new companies formed. 

Qualifications:

• MD, PhD, or an MD/PhD
• 2-3 years of experience in venture capital or equity research
• Experience in the life sciences therapeutics due diligence
• The ability to perform in-depth scientific, medical, and competitive due diligence
• Comfort with AI in daily workflows a plus
• Strong track record in effectively working with senior management
• Proven ability to work collaboratively internally and externally, with the ability to manage multiple stakeholders